GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Labcorp Holdings Inc (LTS:0JSY) » Definitions » Revenue

Labcorp Holdings (LTS:0JSY) Revenue : $12,713 Mil (TTM As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Labcorp Holdings Revenue?

Labcorp Holdings's revenue for the three months ended in Sep. 2024 was $3,282 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2024 was $12,713 Mil. Labcorp Holdings's Revenue per Share for the three months ended in Sep. 2024 was $38.89. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $150.08.

During the past 12 months, the average Revenue per Share Growth Rate of Labcorp Holdings was 10.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was -0.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 4.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was 8.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Labcorp Holdings's highest 3-Year average Revenue per Share Growth Rate was 24.40% per year. The lowest was -21.40% per year. And the median was 10.55% per year.


Labcorp Holdings Revenue Historical Data

The historical data trend for Labcorp Holdings's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labcorp Holdings Revenue Chart

Labcorp Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11,554.80 13,978.50 13,136.10 11,863.90 12,161.60

Labcorp Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,056.80 3,033.30 3,176.60 3,220.90 3,282.00

Competitive Comparison of Labcorp Holdings's Revenue

For the Diagnostics & Research subindustry, Labcorp Holdings's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labcorp Holdings's Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Labcorp Holdings's Revenue distribution charts can be found below:

* The bar in red indicates where Labcorp Holdings's Revenue falls into.



Labcorp Holdings Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $12,713 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Labcorp Holdings  (LTS:0JSY) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Labcorp Holdings Revenue Related Terms

Thank you for viewing the detailed overview of Labcorp Holdings's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Labcorp Holdings Business Description

Traded in Other Exchanges
Address
358 South Main Street, Burlington, NC, USA, 27215
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.

Labcorp Holdings Headlines

No Headlines